Project Grant R01EY036415
Award Date
8/1/24
Completion Date
7/31/28
Dollars Obligated
$410K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
The National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), awarded a $177,464 Project Grant to the University of North Texas Health Science Center at Fort Worth. The grant aims to develop reconstituted high-density lipoprotein (rHDL) nanoparticles for targeted delivery of the neuroprotective agent macitentan to retinal ganglion cells (RGCs) in order to address neurodegeneration and vision loss associated with glaucoma. The key objectives are to: (1) create...
The National Eye Institute (NEI) awarded a $144,362 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The project, titled "Role of Hyperglycemia/Hyperinsulinemia in the Breakdown of the Blood Retinal Barrier in Diabetic Retinopathy," aims to investigate the spatial localization and functions of claudins in the retinal pigment epithelium, and test the hypothesis that...
The National Eye Institute (NEI) awarded a $248,999 Project Grant (CFDA 93.867 - Vision Research) to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University from May 1, 2025 to April 30, 2028. The grant supports research to investigate how neuronal synaptic activity and neurotransmitters, particularly glutamate, influence retinal angiogenesis and blood-retina barrier (BRB) development. The project aims to determine: 1) how modulation of glutamate levels affects retinal...
This Project Grant award from the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) provides $246,000.00 in funding to The University of Texas Southwestern Medical Center to conduct research on the genetic basis and molecular mechanisms of early-onset glaucoma. The research will leverage a high-throughput and unbiased forward genetics pipeline to identify novel gene-phenotype associations related to this blinding disease. The project aims to advance the...
This $477,109 Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) supports research by The University of Texas Southwestern Medical Center to investigate how the PRDM13 transcriptional regulator influences retinal development and its association with North Carolina macular dystrophy. The central hypothesis is that PRDM13 activity during critical periods of retinal development disrupts photoreceptor cell fate determination. The research aims to establish the...
The National Eye Institute (NEI) awarded a $1,298,882 Project Grant (CFDA 93.867 - Vision Research) to the University of Oklahoma Health Sciences Center to investigate the role of extracellular microRNAs (miRNAs) in mediating intercellular communication between retinal pigment epithelium (RPE) and retinal microglia. The primary goals are to study the transfer of extracellular miRNAs between these cell types and evaluate the use of engineered RPE-derived extracellular vesicles (EVs) as an...
This is a Project Grant award from the National Eye Institute (NEI), part of the National Institutes of Health (NIH), under the Vision Research program (CFDA 93.867). The $451,000 award supports research by the University of Texas Southwestern Medical Center to investigate the role of the FIC enzyme in regulating the unfolded protein response (UPR) in the mammalian retina. Specifically, the project aims to determine if FIC-mediated modification of the BIP protein can modulate UPR activation,...
The National Eye Institute (NEI), through the Vision Research federal grant program (CFDA 93.867), awarded a $185,000 Project Grant to the University of North Texas Health Science Center at Fort Worth (UNTHSC). The funding will support a 2-year research project to discover novel disease-modifying therapies for the prevention and treatment of glaucoma. The research will employ computational pharmacological approaches to identify small molecule inhibitors that can interfere with the GREM1-BMP...
This $403,750 Project Grant from the National Eye Institute of the Department of Health and Human Services will fund research into the regulation of retinal microvascular stiffness by the matricellular protein CCN1 and its implications for ischemic retinopathy. The awardee, the Research Foundation for the State University of New York on behalf of SUNY Downstate Health Sciences University, will investigate the effects of CCN1 on the mechanical properties of retinal microvascular endothelial cells...
This Project Grant award, R21EY036552, was provided by the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867). The $191,095 award will support research at the University of North Texas Health Science Center at Fort Worth to investigate how metabolic changes in optic nerve head cells, particularly astrocytes and lamina cribrosa cells, contribute to the development of fibrosis in glaucoma. The key goals are to establish the role of the YAP/TAZ signaling...